Navigation Links
Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
Date:6/1/2008

- Randomized Phase II data show RAD001 significantly increased efficacy of letrozole tablets in women with newly diagnosed hormone-positive breast

cancer - Phase I studies suggest RAD001 may help overcome a major pathway of

resistance to trastuzumab - Novartis to further explore potential of RAD001 in breast cancer by

initiating new trial in early 2009

EAST HANOVER, N.J., June 2 /PRNewswire/ -- Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment strategy for breast cancer by enhancing the efficacy of, and overcoming resistance to, several commonly used breast cancer treatments.

Findings from a Phase II study show that RAD001 enhances tumor shrinkage when given in combination with letrozole tablets (Femara(R)) to postmenopausal women with newly diagnosed estrogen receptor-positive (ER+) breast cancer. Further, initial results from two Phase I trials in which RAD001 was combined with trastuzumab (Herceptin(R)) and chemotherapy agents suggest that the addition of RAD001 overcame resistance to trastuzumab. The combination appears highly active, achieving complete responses in a few patients and partial responses or stable disease in a majority of patients.

These results were among several studies of RAD001 presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois, US. RAD001 is an investigational once-daily oral therapy that may offer a new approach to cancer treatment by continuously inhibiting the mTOR protein, a central regulator of tumor cell division and blood vessel growth in cancer cells.

"The mTOR pathway is a major route to resistance in targeted cancer therapies, and the early data in combination with Herceptin and chemotherapy demonstrate proof of concept that by inhibiting mTOR we may be able to overcome resistance to these medicines,"
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
2. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
3. Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
4. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
5. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
6. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
7. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
8. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
9. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
10. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
11. Gene Therapy Provides Vision to People who Were Nearly Blind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 ... the addition of the  "Global Freeze Drying ... Market - Forecast to 2019"  report to ... ,The global freeze drying market was valued ... expected to reach at $2,655.9 million by ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s ... of Monday, Sept. 29 at 5 p.m. EDT ... Kids!" competition, in response to continued strong interest ... $50,000 each will be awarded to the winning ... Surgical Innovation Symposium hosted by Children,s National in ...
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014  Continua ... leader in healthcare technology, media and telecommunications,  have ... in China and promote ... and BHG announced this new partnership during the ... in Washington, DC , while ...
Breaking Medicine Technology:Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... 2011 Spectrum Dynamics announced today it has shipped ... Telluride (CZT) nuclear imaging modules from a new supplier, ... of Redlen,s first integrated CZT nuclear imaging detector product ... high resolution, low dose nuclear medicine cameras. ...
... Covidien Plc (COV: $53) has been picked by ... of the Week.  COV carries S&P,s highest investment recommendation ... the largest suppliers in the world of certain medical ... or number-two in businesses representing more than 75% of ...
Cached Medicine Technology:Spectrum Dynamics Announces Shipment of Revolutionary D-SPECT™ Cardiac Imaging Systems Using Redlen's New CZT Nuclear Imaging Modules 2Spectrum Dynamics Announces Shipment of Revolutionary D-SPECT™ Cardiac Imaging Systems Using Redlen's New CZT Nuclear Imaging Modules 3S&P Equity Research Picks COV Focus Stock of the Week 2S&P Equity Research Picks COV Focus Stock of the Week 3S&P Equity Research Picks COV Focus Stock of the Week 4
(Date:9/23/2014)... Ale Gicqueau, President and Chairman at ... for Clinical Trials at the upcoming Pharmaceutical Users ... Friday, September 26, 2014. , PhUSE is an ... PhUSE has expanded from its roots as a conference ... the discussion of topics encompassing the work of data ...
(Date:9/23/2014)... Many people have very limited knowledge and faulty understanding of ... in which a hypnotist induces a trance-like state in a ... suggestion to have them do his bidding, often to entertaining ... aid in managing bad habits like smoking and overeating. But ... can be used. “Hypnosis can facilitate treatment for a wide ...
(Date:9/22/2014)... Petersburg, FL (PRWEB) September 23, 2014 ... of wrinkles. A Sublime Beauty® cream helps to ... botox), boost collagen levels and hydrate beautifully. , ... is a multi-tasker for aging skin," says Kathy ... known as the natural botox, wrinkles are relaxed ...
(Date:9/22/2014)... Utah (PRWEB) September 23, 2014 ... and corporate training, will be attending and exhibiting ... the American Health Information Management Association (AHIMA) in ... September 27 through October 1, and Career Step ... on its suite of coding training products, including ...
(Date:9/22/2014)... 2014 Airbus Helicopters Inc. (AHI) honored ... their efforts to improve safety and quality of service. ... Program of the Year award, both sponsored by AHI, ... Conference Annual Community Awards. , PHI Air Medical ... Charlson Aviation Safety Award, given annually to an individual ...
Breaking Medicine News(10 mins):Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 2Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 3Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 4Health News:How to Reduce Wrinkles and Improve Aging Skin from Sublime Beauty®; One Day Sale on Now 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3
... to the value of 17.4 billion Norwegian kroners (NOK) were ... 700 kroner per inhabitant. The increase in 2007 was 3.4 ... Drug Statistics maintained by the Norwegian Institute of Public Health. ... in 2007 by 4.9 percent and in 2006 the increase ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... D. Singer, Chief,Executive Officer, is scheduled to present on ... Health Care Conference in Boston, MA. Jeffrey,Taylor, President and ... Event: Deutsche Bank Health Care Conference ...
... Crystal Research Associates, LLC,announced today that it ... Inc. (OTC Bulletin Board: BOCX). The full 52-page,report ... BioCurex, Inc. ("BioCurex" or "the Company") is a ... therapy that target,a global oncology market forecast to ...
... Taxpayers Union Says Extending,Private Coverage for Dialysis Patients ... Care and Generating Taxpayer Savings, WASHINGTON, April ... of patient advocates, dialysis professionals, care,providers and manufacturers ... with kidney disease and kidney failure - applauded ...
... Puzzle ... on the Human Body and Mind, GREENVILLE, N.C. ... Recreation and Leisure Studies today revealed,the results of a ... other mood-lifting effects of so-called "casual",video games. The three ...
... helps pinpoint relationship between Crohn,s disease and colitis , , ... diseases ulcerative colitis and Crohn,s disease appear to share ... studies suggest. , Though similar in many ways, the ... to pinpoint the underlying relationship between them to improve ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3Health News:Kidney Care Community Applauds National Taxpayers Union's Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal 'Common Sense Coverage Reform' 2Health News:Kidney Care Community Applauds National Taxpayers Union's Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal 'Common Sense Coverage Reform' 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... Immuno Concepts manufactures slides that are compatible ... to decrease the number of pipetting steps ... sample dilutions on the slides. Ask Immuno ... and these slides. These slide formats are ...
... patented HEp-2 cell line that has been ... SS-A/Ro autoantibodies, without affecting the other ANA ... published worldwide on the HEp-2000 ANA substrate, ... when used in place of standard HEp-2 ...
... patented HEp-2 cell line that has been ... SS-A/Ro autoantibodies, without affecting the other ANA ... published worldwide on the HEp-2000 ANA substrate, ... when used in place of standard HEp-2 ...
Medicine Products: